Benefits
Autophagy: shown in cells and animals, only small pilot data in people
In cell and animal studies, spermidine is a well-characterized inducer of autophagy, the cellular self-cleaning process that removes damaged proteins, dysfunctional organelles and protein aggregates. In laboratory studies it acts through its role in hypusination of eukaryotic translation initiation factor 5A (eIF5A), which is essential for translation of autophagy-related proteins. Some studies report lower spermidine levels in older people, but whether this contributes to aging in humans is not known. Human evidence that spermidine supplements raise autophagy is thin and comes from other products. A 12-person, 8-week pilot with no placebo group, run by the extract's supplier, reported small rises from baseline in two autophagy markers (Beclin-1 by 7.3% and ULK1 by 13.4%) at 3.3 mg/day from a rice-germ extract, and a 40-person placebo-controlled pilot in adults over 65 taking 6 mg/day reported higher activity of autophagy-related genes in immune cells. In a 28-day trial of purified spermidine at 40 mg/day and a 5-day trial of a food-based supplement at 15 mg/day, blood spermidine levels did not meaningfully rise.
Longevity and heart health: animal studies and observational diet data only
In mice, oral spermidine extended lifespan and protected the aging heart, and in salt-sensitive rats it lowered blood pressure. These mechanisms (cardiac autophagy, less inflammation, more elastic heart muscle cells) were shown in animals, not people. In people, diets higher in spermidine were associated with lower blood pressure, less cardiovascular disease and lower all-cause mortality in Italian and Austrian cohorts. In UK Biobank, total dietary polyamines were associated with lower mortality, but risk was lowest at moderate intakes, not the highest. These are observational diet studies and cannot show that a spermidine supplement protects the heart or extends life. In the one 12-month supplement trial (SmartAge, a wheat-germ extract), vital signs and other cardiovascular risk factors were secondary outcomes and did not change significantly.
Memory: the 12-month trial found no benefit
In older adults with subjective memory complaints, a 12-month randomized trial (SmartAge, 100 people) of a wheat-germ extract giving 0.9 mg spermidine per day found no effect on memory or on biomarkers compared with placebo. An earlier 3-month pilot in 30 people had reported a moderate memory effect with a confidence interval reaching zero, and the larger trial did not confirm it. Neither trial tested Yüth® or its 3 to 5 mg dose. Effects on nerve-cell autophagy come from animal studies, and it has not been shown that supplemental spermidine reaches the human brain.
Aging pathways: laboratory and animal evidence only
In yeast, worms, flies and mice, spermidine switches on autophagy, lowers inflammatory signalling and extends lifespan, which is why researchers call it a caloric restriction mimetic. In people these effects are unproven: the 12-month SmartAge trial found no change in inflammatory markers, and human autophagy-marker data come only from two small pilots of other spermidine products. There is no human evidence that spermidine supplements extend healthspan or lifespan, and no study has tested Yüth® itself.
Mechanism of action
eIF5A Hypusination and Autophagy Induction (Lab and Animal Data)
Spermidine is needed for hypusination of eukaryotic translation initiation factor 5A (eIF5A), a modification that cell studies show is required to make some autophagy-related proteins. Through this route spermidine switches on autophagy, the process that clears damaged proteins and organelles, in cells and animals. This has not been shown in people taking a supplement.
Caloric Restriction Mimetic
Spermidine activates many of the same longevity pathways as caloric restriction (autophagy, AMPK, reduced mTOR signaling) without requiring caloric reduction in animal and cell studies, which is why it is described as a caloric restriction mimetic. This has not been shown in people.
Anti-Inflammatory Cytokine Modulation
In animal and cell studies spermidine lowers TNF-α and other inflammatory cytokines. In the 12-month human trial, inflammatory biomarkers did not change significantly; only exploratory analyses hinted at an effect.
Mitochondrial Quality Control (Lab and Animal Data)
Autophagy clears damaged mitochondria (mitophagy), and in cell and animal studies spermidine has been linked to better mitochondrial function. This has not been measured in people.
Clinical trials
12-month randomized, double-blind, placebo-controlled phase 2b trial (SmartAge) of a spermidine-rich wheat-germ extract giving 0.9 mg spermidine per day, not Yüth®. Published in JAMA Network Open, 2022.
100 adults aged 60 to 90 with subjective cognitive decline (51 spermidine, 49 placebo); 89 completed.
No effect on the primary memory outcome versus placebo (mnemonic discrimination; between-group difference -0.03, 95% CI -0.11 to 0.05, P = .47), and no effect on secondary outcomes or biomarkers. Exploratory analyses hinted at effects on verbal memory and inflammation that the authors said need testing at higher doses. This larger, longer trial did not confirm the pilot result.
3-month randomized, double-blind, placebo-controlled phase 2a pilot of a spermidine-rich wheat-germ extract (1.2 mg spermidine per day), not Yüth®. Memory results published in Cortex 2018; safety results from the same 30 participants published in Aging 2018.
30 cognitively intact older adults (60-80 years) with subjective cognitive decline.
Memory scores were higher than placebo at 3 months (Cohen's d 0.77, 95% CI 0 to 1.53), but the between-group difference had a confidence interval of -0.01 to 0.35, which includes zero. This was a 30-person pilot analysed by effect size, and the larger 12-month SmartAge trial that followed found no memory benefit.
Prospective population cohort relating dietary spermidine intake (food-frequency questionnaires) to mortality. Not a trial: no supplement was given. Kiechl et al., American Journal of Clinical Nutrition, 2018.
829 adults aged 45 to 84 in Bruneck, Italy, followed from 1995 to 2015 (341 deaths).
Higher dietary spermidine intake was associated with lower all-cause mortality (hazard ratio 0.76 per 1-SD higher intake after adjustment for lifestyle and other dietary factors), replicated in the smaller SAPHIR cohort. Critical caveat: observational, not interventional; cannot establish causation; dietary spermidine may correlate with other healthful dietary patterns.